3351 - 3400 of 8620 Results
Title
Year
-
RESTRICTEDTitle: LRRK2 signaling in neurodegeneration: two decades of progressJournal Name: Essays in BiochemistryPublisher: Portland Press Ltd.Vol: 65Issue #: 7Start Page: 859End Page: 872Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1042/ebc20210013Citation Count: 10
- Modelling the functional genomics of Parkinson’s disease inCaenorhabditis elegans:LRRK2and beyond2021RESTRICTEDTitle: Modelling the functional genomics of Parkinson’s disease inCaenorhabditis elegans:LRRK2and beyondJournal Name: Bioscience ReportsPublisher: Portland Press Ltd.Vol: 41Issue #: 9Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1042/bsr20203672Best OA location URL: https://portlandpress.com/bioscirep/article-pdf/41/9/BSR20203672/920054/bsr-2020-3672c.pdfCitation Count: 9
- Chronic Traumatic Encephalopathy: A Comparison with Alzheimer's Disease and Frontotemporal Dementia2020RESTRICTEDTitle: Chronic Traumatic Encephalopathy: A Comparison with Alzheimer's Disease and Frontotemporal DementiaJournal Name: Seminars in NeurologyPublisher: Georg Thieme Verlag KGVol: 40Issue #: 04Start Page: 394End Page: 410Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1055/s-0040-1715134Citation Count: 8
-
RESTRICTEDTitle: Allosteric inhibition of LRRK2, where are we nowJournal Name: Biochemical Society TransactionsPublisher: Portland Press Ltd.Vol: 48Issue #: 5Start Page: 2185End Page: 2194Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1042/bst20200424Best OA location URL: https://portlandpress.com/biochemsoctrans/article-pdf/48/5/2185/896516/bst-2020-0424c.pdfCitation Count: 10
- Platelet Behavior Contributes to Neuropathologies: A Focus on Alzheimer's and Parkinson's Disease2021RESTRICTEDTitle: Platelet Behavior Contributes to Neuropathologies: A Focus on Alzheimer's and Parkinson's DiseaseJournal Name: Seminars in Thrombosis and HemostasisPublisher: Georg Thieme Verlag KGVol: 48Issue #: 03Start Page: 382End Page: 404Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1055/s-0041-1733960Citation Count: 5
-
RESTRICTEDTitle: On demand therapy for Parkinson’s disease patients: Opportunities and choicesJournal Name: Postgraduate MedicinePublisher: Informa UK LimitedVol: 133Issue #: 7Start Page: 721End Page: 727Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1080/00325481.2021.1936087Best OA location URL: https://www.tandfonline.com/doi/pdf/10.1080/00325481.2021.1936087?needAccess=trueCitation Count: 16
- Pregabalin for neuropathic pain in primary care settings: recommendations for dosing and titration2021RESTRICTEDTitle: Pregabalin for neuropathic pain in primary care settings: recommendations for dosing and titrationJournal Name: Postgraduate MedicinePublisher: Informa UK LimitedVol: 133Issue #: 1Start Page: 1End Page: 9Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1080/00325481.2020.1857992Best OA location URL: https://www.tandfonline.com/doi/pdf/10.1080/00325481.2020.1857992?needAccess=trueCitation Count: 10
-
RESTRICTEDTitle: A systematic review of group intervention for acquired dysarthria in adultsJournal Name: Disability and RehabilitationPublisher: Informa UK LimitedVol: 44Issue #: 13Start Page: 3002End Page: 3018Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/09638288.2020.1859629Citation Count: 9
-
RESTRICTEDTitle: Targeting mitophagy in Parkinson's diseaseJournal Name: Journal of Biological ChemistryPublisher: Elsevier BVVol: 296Issue #:Start Page: 100209End Page: 100209Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1074/jbc.rev120.014294Best OA location URL: https://doi.org/10.1074/jbc.rev120.014294Citation Count: 72
-
RESTRICTEDTitle: Emerging drugs for the treatment of L-DOPA-induced dyskinesia: an updateJournal Name: Expert Opinion on Emerging DrugsPublisher: Informa UK LimitedVol: 25Issue #: 2Start Page: 131End Page: 144Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/14728214.2020.1763954Citation Count: 13
-
RESTRICTEDTitle: Identifying and responding to fatigue and apathy in Parkinson’s disease: a review of current practiceJournal Name: Expert Review of NeurotherapeuticsPublisher: Informa UK LimitedVol: 20Issue #: 5Start Page: 477End Page: 495Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/14737175.2020.1752669Citation Count: 29
-
RESTRICTEDTitle: Therapeutic innovation in Parkinson’s disease: a 2020 update on disease-modifying approachesJournal Name: Expert Review of NeurotherapeuticsPublisher: Informa UK LimitedVol: 20Issue #: 10Start Page: 1047End Page: 1064Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/14737175.2020.1800454Citation Count: 12
-
RESTRICTEDTitle: The necroptosis pathway and its role in age-related neurodegenerative diseases: will it open up new therapeutic avenues in the next decade?Journal Name: Expert Opinion on Therapeutic TargetsPublisher: Informa UK LimitedVol: 24Issue #: 7Start Page: 679End Page: 693Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/14728222.2020.1758668Citation Count: 14
-
RESTRICTEDTitle: A critical review of apomorphine hydrochloride sublingual film for the treatment of Parkinson’s disease ‘OFF’ episodesJournal Name: Expert Review of NeurotherapeuticsPublisher: Informa UK LimitedVol: 21Issue #: 2Start Page: 169End Page: 177Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/14737175.2020.1855145Citation Count: 9
- Redefining the strategy for the use of COMT inhibitors in Parkinson’s disease: the role of opicapone2021RESTRICTEDTitle: Redefining the strategy for the use of COMT inhibitors in Parkinson’s disease: the role of opicaponeJournal Name: Expert Review of NeurotherapeuticsPublisher: Informa UK LimitedVol: 21Issue #: 9Start Page: 1019End Page: 1033Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1080/14737175.2021.1968298Best OA location URL: https://www.tandfonline.com/doi/pdf/10.1080/14737175.2021.1968298?needAccess=trueCitation Count: 20
- Noninvasive vagus nerve stimulation in Parkinson’s disease: current status and future prospects2021RESTRICTEDTitle: Noninvasive vagus nerve stimulation in Parkinson’s disease: current status and future prospectsJournal Name: Expert Review of Medical DevicesPublisher: Informa UK LimitedVol: 18Issue #: 10Start Page: 971End Page: 984Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1080/17434440.2021.1969913Best OA location URL: https://doi.org/10.1080/17434440.2021.1969913Citation Count: 17
-
RESTRICTEDTitle: Advances in protein-protein interaction network analysis for Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 155Issue #:Start Page: 105395End Page: 105395Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.nbd.2021.105395Best OA location URL: https://doi.org/10.1016/j.nbd.2021.105395Citation Count: 31
-
RESTRICTEDTitle: Hallucinations and delusions associated with Parkinson’s disease psychosis: safety of current treatments and future directionsJournal Name: Expert Opinion on Drug SafetyPublisher: Informa UK LimitedVol: 21Issue #: 7Start Page: 873End Page: 879Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1080/14740338.2022.2069240Best OA location URL: https://doi.org/10.1080/14740338.2022.2069240Citation Count: 8
-
RESTRICTEDTitle: Neuropathological evidence of body-first vs. brain-first Lewy body diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 161Issue #:Start Page: 105557End Page: 105557Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.nbd.2021.105557Best OA location URL: https://doi.org/10.1016/j.nbd.2021.105557Citation Count: 87
-
RESTRICTEDTitle: Immune responses in the Parkinson's disease brainJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 168Issue #:Start Page: 105700End Page: 105700Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2022.105700Best OA location URL: https://doi.org/10.1016/j.nbd.2022.105700Citation Count: 35
-
RESTRICTEDTitle: Treatment of Nonmotor Symptoms Associated with Parkinson DiseaseJournal Name: Neurologic ClinicsPublisher: Elsevier BVVol: 38Issue #: 2Start Page: 269End Page: 292Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.ncl.2019.12.003Citation Count: 25
-
RESTRICTEDTitle: LRRK2 as a target for modulating immune system responsesJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 169Issue #:Start Page: 105724End Page: 105724Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2022.105724Best OA location URL: https://doi.org/10.1016/j.nbd.2022.105724Citation Count: 14
-
RESTRICTEDTitle: Understanding the potential causes of gastrointestinal dysfunctions in multiple system atrophyJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 187Issue #:Start Page: 106296End Page: 106296Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.nbd.2023.106296Best OA location URL: https://doi.org/10.1016/j.nbd.2023.106296Citation Count: 1
-
RESTRICTEDTitle: Evidence for immune system alterations in peripheral biological fluids in Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 170Issue #:Start Page: 105744End Page: 105744Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.nbd.2022.105744Best OA location URL: https://doi.org/10.1016/j.nbd.2022.105744Citation Count: 16
-
RESTRICTEDTitle: The roles of connectivity and neuronal phenotype in determining the pattern of α-synuclein pathology in Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 168Issue #:Start Page: 105687End Page: 105687Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.nbd.2022.105687Best OA location URL: https://doi.org/10.1016/j.nbd.2022.105687Citation Count: 14
-
RESTRICTEDTitle: Surgical Treatment of Parkinson DiseaseJournal Name: Neurologic ClinicsPublisher: Elsevier BVVol: 38Issue #: 2Start Page: 293End Page: 307Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.ncl.2020.01.001Best OA location URL: http://manuscript.elsevier.com/S0733861920300013/pdf/S0733861920300013.pdfCitation Count: 13
-
RESTRICTEDTitle: Treatment of Tardive DyskinesiaJournal Name: Neurologic ClinicsPublisher: Elsevier BVVol: 38Issue #: 2Start Page: 379End Page: 396Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.ncl.2020.01.004Citation Count: 27
-
RESTRICTEDTitle: An Overview of the Current State and the Future of Ataxia TreatmentsJournal Name: Neurologic ClinicsPublisher: Elsevier BVVol: 38Issue #: 2Start Page: 449End Page: 467Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.ncl.2020.01.008Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220524Citation Count: 13
-
RESTRICTEDTitle: Neuroimaging the consciousness of self: Review, and conceptual-methodological frameworkJournal Name: Neuroscience & Biobehavioral ReviewsPublisher: Elsevier BVVol: 112Issue #:Start Page: 164End Page: 212Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.neubiorev.2020.01.023Best OA location URL: https://doi.org/10.1016/j.neubiorev.2020.01.023Citation Count: 109
-
RESTRICTEDTitle: An updated reappraisal of synapsins: structure, function and role in neurological and psychiatric disordersJournal Name: Neuroscience & Biobehavioral ReviewsPublisher: Elsevier BVVol: 130Issue #:Start Page: 33End Page: 60Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neubiorev.2021.08.011Citation Count: 24
-
RESTRICTEDTitle: Dysfunction of the autophagy/lysosomal degradation pathway is a shared feature of the genetic synucleinopathiesJournal Name: The FASEB JournalPublisher: WileyVol: 27Issue #: 9Start Page: 3424End Page: 3429Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1096/fj.12-223842Best OA location URL: https://doi.org/10.1096/fj.12-223842Citation Count: 60
-
RESTRICTEDTitle: LRRK2 in Parkinson’s disease: function in cells and neurodegenerationJournal Name: The FEBS JournalPublisher: WileyVol: 276Issue #: 22Start Page: 6436End Page: 6444Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/j.1742-4658.2009.07342.xBest OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1742-4658.2009.07342.xCitation Count: 32
-
RESTRICTEDTitle: LRRK2 in Parkinson’s disease: in vivo models and approaches for understanding pathogenic rolesJournal Name: The FEBS JournalPublisher: WileyVol: 276Issue #: 22Start Page: 6445End Page: 6454Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/j.1742-4658.2009.07343.xBest OA location URL: https://europepmc.org/articles/pmc2827245?pdf=renderCitation Count: 21
-
RESTRICTEDTitle: Bent out of shape: α‐Synuclein misfolding and the convergence of pathogenic pathways in Parkinson's diseaseJournal Name: FEBS LettersPublisher: WileyVol: 589Issue #: 24PartAStart Page: 3749End Page: 3759Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.febslet.2015.10.023Best OA location URL: https://febs.onlinelibrary.wiley.com/doi/pdfdirect/10.1016/j.febslet.2015.10.023Citation Count: 55
-
RESTRICTEDTitle: Cellular processes associated with LRRK2 function and dysfunctionJournal Name: The FEBS JournalPublisher: WileyVol: 282Issue #: 15Start Page: 2806End Page: 2826Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1111/febs.13305Best OA location URL: https://doi.org/10.1111/febs.13305Citation Count: 133
-
RESTRICTEDTitle: PINK1 and Parkin – mitochondrial interplay between phosphorylation and ubiquitylation in Parkinson's diseaseJournal Name: The FEBS JournalPublisher: WileyVol: 282Issue #: 2Start Page: 215End Page: 223Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1111/febs.13127Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/febs.13127Citation Count: 86
-
RESTRICTEDTitle: Endoplasmic Reticulum-Based Calcium Dysfunctions in SynucleinopathiesJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2021.742625Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2021.742625/pdfCitation Count: 10
-
RESTRICTEDTitle: The Role of microRNAs in Mitochondria: Small Players Acting WideJournal Name: GenesPublisher: MDPI AGVol: 5Issue #: 4Start Page: 865End Page: 886Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/genes5040865Best OA location URL: https://www.mdpi.com/2073-4425/5/4/865/pdf?version=1411736411Citation Count: 116
-
RESTRICTEDTitle: Identifying Risk Genes and Interpreting Pathogenesis for Parkinson’s Disease by a Multiomics AnalysisJournal Name: GenesPublisher: MDPI AGVol: 11Issue #: 9Start Page: 1100End Page: 1100Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/genes11091100Best OA location URL: https://www.mdpi.com/2073-4425/11/9/1100/pdf?version=1600677065Citation Count: 14
-
RESTRICTEDTitle: Where attention falls: Increased risk of falls from the converging impact of cortical cholinergic and midbrain dopamine loss on striatal functionJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 257Issue #:Start Page: 120End Page: 129Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2014.04.032Best OA location URL: https://europepmc.org/articles/pmc4348073?pdf=renderCitation Count: 92
-
RESTRICTEDTitle: Targeting urate to reduce oxidative stress in Parkinson diseaseJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 298Issue #:Start Page: 210End Page: 224Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.expneurol.2017.06.017Best OA location URL: http://manuscript.elsevier.com/S0014488617301577/pdf/S0014488617301577.pdfCitation Count: 103
-
RESTRICTEDTitle: Monogenic Parkinson’s Disease: Genotype, Phenotype, Pathophysiology, and Genetic TestingJournal Name: GenesPublisher: MDPI AGVol: 13Issue #: 3Start Page: 471End Page: 471Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/genes13030471Best OA location URL: https://www.mdpi.com/2073-4425/13/3/471/pdf?version=1646672241Citation Count: 47
-
RESTRICTEDTitle: AAV Vector-Mediated Gene Delivery to Substantia Nigra Dopamine Neurons: Implications for Gene Therapy and Disease ModelsJournal Name: GenesPublisher: MDPI AGVol: 8Issue #: 2Start Page: 63End Page: 63Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/genes8020063Best OA location URL: https://www.mdpi.com/2073-4425/8/2/63/pdf?version=1486965246Citation Count: 45
-
RESTRICTEDTitle: The advent of AAV9 expands applications for brain and spinal cord gene deliveryJournal Name: Expert Opinion on Biological TherapyPublisher: Informa HealthcareVol: 12Issue #: 6Start Page: 757End Page: 766Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1517/14712598.2012.681463Best OA location URL: https://europepmc.org/articles/pmc3361729?pdf=renderCitation Count: 119
-
RESTRICTED
-
RESTRICTEDTitle: Remote delivery of cognitive behavioral therapy to patients with functional neurological disorders: Promise and challengesJournal Name: Epilepsy & Behavior ReportsPublisher: Elsevier BVVol: 16Issue #:Start Page: 100469End Page: 100469Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.ebr.2021.100469Best OA location URL: https://doi.org/10.1016/j.ebr.2021.100469Citation Count: 15
-
RESTRICTEDTitle: The microtubule associated protein tau H1 haplotype and risk of essential tremorJournal Name: European Journal of NeurologyPublisher: WileyVol: 21Issue #: 7Start Page: 1044End Page: 1048Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/ene.12335Best OA location URL: https://europepmc.org/articles/pmc4057305?pdf=renderCitation Count: 12
-
RESTRICTEDTitle: Tau acts as a mediator for Alzheimer's disease‐related synaptic deficitsJournal Name: European Journal of NeurosciencePublisher: WileyVol: 39Issue #: 7Start Page: 1202End Page: 1213Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/ejn.12504Best OA location URL: https://europepmc.org/articles/pmc3983570?pdf=renderCitation Count: 44
-
RESTRICTEDTitle: Iron- and Neuromelanin-Weighted Neuroimaging to Study Mitochondrial Dysfunction in Patients with Parkinson’s DiseaseJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 23Issue #: 22Start Page: 13678End Page: 13678Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms232213678Best OA location URL: https://www.mdpi.com/1422-0067/23/22/13678/pdf?version=1668567593Citation Count: 6
-
RESTRICTEDTitle: Targeting the Complement–Sphingolipid System in COVID-19 and Gaucher Diseases: Evidence for a New Treatment StrategyJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 23Issue #: 22Start Page: 14340End Page: 14340Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms232214340Best OA location URL: https://www.mdpi.com/1422-0067/23/22/14340/pdf?version=1669106553Citation Count: 8